Stay updated on Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Sign up to get notified when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.

Latest updates to the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedUpdated the displayed ClinicalTrials.gov interface/app revision label from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check25 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.5.0 added to the history; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry v3.4.3 was added to the record history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.4.2 was added, replacing v3.4.1. A funding/operating-status notice was removed; these updates pertain to site-wide notices rather than the study record content.SummaryDifference0.5%

- Check97 days agoChange DetectedAdded a government funding notice and a new Revision: v3.4.1. The previous Revision: v3.4.0 entry was removed.SummaryDifference0.5%

Stay in the know with updates to Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.